PRTK - Paratek Pharmaceuticals Inc. (PRTK) CEO Evan Loh on Q1 2021 Results - Earnings Call Transcript
Paratek Pharmaceuticals, Inc. (PRTK) Q1 2021 Earnings Conference Call May 17, 2021 08:30 ET Company Participants Ben Strain - Vice President of Investor Relations Evan Loh - Chief Executive Officer Adam Woodrow - President & Chief Commercial Officer Randy Brenner - Chief Development & Regulatory Officer Michael Bigham - Executive Chairman Sarah Higgins - Vice President of Finance Controller & Principal Accounting Officer Conference Call Participants Ed Arce - H.C. Wainwright Bert Hazlett - BTIG Kevin Kedra - G. Research Suji Jeong - Jefferies Presentation Operator Greetings. Welcome to Paratek Pharmaceuticals' First Quarter 2021 Earnings Call. At this time, all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] At this time, I'll turn the conference over to Ben Strain, Vice President Investor Relations. Ben, you may now begin. Ben Strain Good morning and welcome to Paratek's First Quarter 2021 Earnings and Corporate Update
For further details see:
Paratek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q1 2021 Results - Earnings Call Transcript